Longaeva Partners »

Avalyn Pharma shares owned by Longaeva Partners

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $412k 13k 32.92

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Avalyn Pharma

FMR
Novo A/S
Sr One Capital Management
Perceptive Advisors
Suvretta Capital Management
NVP Associates
Wellington Management Company
Catalio Capital Management
Eventide Asset Management
Bellevue Group
BlackRock
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Andera Partners
Jennison Associates

View all funds holding Avalyn Pharma